Success Metrics

Clinical Success Rate
89.4%

Based on 203 completed trials

Completion Rate
89%(203/227)
Active Trials
40(11%)
Results Posted
33%(67 trials)
Terminated
24(6%)

Phase Distribution

Ph phase_3
82
22%
Ph phase_4
123
32%
Ph phase_2
52
14%
Ph phase_1
19
5%
Ph not_applicable
82
22%
Ph early_phase_1
10
3%

Phase Distribution

29

Early Stage

52

Mid Stage

205

Late Stage

Phase Distribution368 total trials
Early Phase 1First-in-human
10(2.7%)
Phase 1Safety & dosage
19(5.2%)
Phase 2Efficacy & side effects
52(14.1%)
Phase 3Large-scale testing
82(22.3%)
Phase 4Post-market surveillance
123(33.4%)
N/ANon-phased studies
82(22.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.5%

203 of 249 finished

Non-Completion Rate

18.5%

46 ended early

Currently Active

40

trials recruiting

Total Trials

380

all time

Status Distribution
Active(56)
Completed(203)
Terminated(46)
Other(75)

Detailed Status

Completed203
unknown73
Recruiting36
Terminated24
Withdrawn22
Not yet recruiting13

Development Timeline

Analytics

Development Status

Total Trials
380
Active
40
Success Rate
89.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 110 (2.7%)
Phase 119 (5.2%)
Phase 252 (14.1%)
Phase 382 (22.3%)
Phase 4123 (33.4%)
N/A82 (22.3%)

Trials by Status

enrolling_by_invitation31%
not_yet_recruiting133%
unknown7319%
withdrawn226%
terminated246%
suspended21%
recruiting369%
completed20353%
active_not_recruiting41%

Recent Activity

Clinical Trials (380)

Showing 20 of 380 trialsScroll for more
NCT06970483Phase 4

Comparison of the Efficacy of Misoprostol and Tranexamic Acid for Postpartum Hemorrhage Prophylaxis in Cesarean Delivery

Completed
NCT06266546Phase 3

Prophylactic Endobronchial Tranexamic Acid to Reduce Bleeding in Transbronchial Cryobiopsy

Active Not Recruiting
NCT06422273Phase 3

Protest Trial: TXA vs Saline

Enrolling By Invitation
NCT07714473Not Applicable

Evaluation of the Therapeutic Effect of Local Application of Tranexamic Acid in Rotator Cuff Repair

Not Yet Recruiting
NCT05053867Phase 3

A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients

Recruiting
NCT03364491Phase 3

Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean

Completed
NCT04905901Phase 3

Nebulized Tranexamic Acid in Sinus Surgery

Completed
NCT06820177Phase 4

Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes

Recruiting
NCT07644923Phase 4

Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated Coagulation

Not Yet Recruiting
NCT07614087Phase 4

Plasma Concentrations of Intraosseous Versus Intravenous Tranexamic Acid in Joint Arthroplasty

Not Yet Recruiting
NCT03364569

Usefullness of Peri-operative Tranexamic Acid in Primary Breast Augmentation With Implants.

Completed
NCT06657924Phase 2

Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery

Recruiting
NCT07582341Phase 4

Combined Intravenous and Irrigation Tranexamic Acid During Percutaneous Nephrolithotomy

Completed
NCT05774717Phase 1

Tranexamic Acid in Rhinoplasty: Perioperative Bleeding, Edema and Ecchymosis

Recruiting
NCT02314988Phase 2

Tranexamic Acid to Reduce Blood Loss in Spine Surgery

Recruiting
NCT06414031Phase 3

Tranexamic Acid for Reduction of Transfusion in Abdominal Surgery

Recruiting
NCT06208267Not Applicable

Tranexamic Acid Use on Pain, Mobility and Bleeding Following Total Hip and Total Knee Arthroplasty

Recruiting
NCT06599762Phase 2

Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia

Recruiting
NCT02702128Phase 3

Preventive EXACYL® on Perioperative Bleeding During Orthognathism of Maxillary Surgery

Completed
NCT07501884Phase 4

REDUCER Trial (TXA in Urethroplasty)

Not Yet Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
380